Mesoblast MESO Slides 080 as Selling Pressure Mounts 20260518 Jio Financial Block Deal Goldman Sachs Sells 62 Crore Stake to Morgan Stanley Modular Data Center Builder Armada Secures 230 Million Plans Arizona Factory with Johnson Controls Compass COMP Up 161 Is There More Room to Run 20260515 MRBK Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Banzai BNZIW Declines 407 Amid Market Weakness 20260520 NexPoint NXRT Delivers Q1 2026 Beat EPS 027 vs 037 Expected SoftBank Group Surges Nearly 20 Amid Reports of OpenAI and SB Energy US IPOs Caribbean Property Rights Strain as Foreign Investment Reshapes Coastal Access SP 500 Edges Higher as Utilities Lead Communication Services Drag Expert View Waterfield Advisors Suggests Staggered Accumulation as Peak Macro Concerns Ease Salesforce Reports Earnings and Revenue Beat But FullYear Outlook Disappoints Grabs CTO on Physical AI and Automated Driving Why He Keeps Competitors Robots in the Office Bitcoin Drops Below 77000 Amid Escalating USIran Tensions and Spot ETF Outflows Cypherpunk Technologies Q3 2025 Earnings Narrowed Loss Beats Estimates Yet Shares Dip OPRX Q1 2026 Earnings Massive EPS Beat Driven by Strong Operational Performance First Citizens BancShares FCNCN Q1 2026 Earnings Strong EPS Beat Amid Stable Preferred Stock Performance AVNS Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise Despite Revenue Uncertainty NEPH Q1 2026 Earnings Narrow EPS Miss Triggers Modest Selloff Standard Chartered to Trim Over 15 of Corporate Functions Roles in Push for Higher Returns Sonoco Products SON Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Outset Medical Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher APRE Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline NSA Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Decline CLOV Q1 2026 Earnings Strong EPS Surprise of 12876 Amid Revenue Uncertainty Sensei Biotherapeutics Inc SNSE Q1 2026 Earnings Deep EPS Miss Reflects Heavy RD Investment and PreRevenue Status PROK Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Development Continues COSM Q1 2026 Earnings EPS Misses Estimates Significantly Stock Rises 4